Uptrend support has held.
Cluster of moving averages now resistance
News release
Co-Diagnostics (NASDAQ:CODX) perks up 10% premarket on light volume on the heels of performance data on its LogixSmart real-time PCR test that detects RNA from the SARS-CoV-2 virus in lower respiratory tract fluids.
Tests performed in Australia (n=207), India (n=45) and Mexico (n not provided) showed 100% sensitivity and 100% specificity with no cross-reactivity with other viruses.
It also says that the test detected more low-level positives than the CDC test while testing at the Minnesota Department of Health showed 100% concordance with another (unnamed) assay.
Source Seekingalpha
Cluster of moving averages now resistance
News release
Co-Diagnostics (NASDAQ:CODX) perks up 10% premarket on light volume on the heels of performance data on its LogixSmart real-time PCR test that detects RNA from the SARS-CoV-2 virus in lower respiratory tract fluids.
Tests performed in Australia (n=207), India (n=45) and Mexico (n not provided) showed 100% sensitivity and 100% specificity with no cross-reactivity with other viruses.
It also says that the test detected more low-level positives than the CDC test while testing at the Minnesota Department of Health showed 100% concordance with another (unnamed) assay.
Source Seekingalpha
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。